Yes, certain enzymes can serve as biomarkers for cancer diagnosis, prognosis, and treatment response. For instance:
- Prostate-Specific Antigen (PSA): An enzyme used as a biomarker for prostate cancer. - Alpha-fetoprotein (AFP): Elevated levels of this enzyme can indicate liver cancer. - Lactate Dehydrogenase (LDH): High levels of LDH are often found in various cancers and can be used to monitor treatment efficacy.
